دورية أكاديمية

Synthesis of homologous series of surfactants from renewable resources, structure-properties relationship, surface active performance, evaluation of their antimicrobial and anticancer potentialities.

التفاصيل البيبلوغرافية
العنوان: Synthesis of homologous series of surfactants from renewable resources, structure-properties relationship, surface active performance, evaluation of their antimicrobial and anticancer potentialities.
المؤلفون: Abdelaziz SA; Chemistry Department, Faculty of Science, Al-Azhar University (Girls), Cairo, Egypt. Shimaaabdelaziz.59@azhar.edu.eg., Ahmed EM; Chemistry Department, Faculty of Science, Al-Azhar University (Girls), Cairo, Egypt., Sadek M; Chemistry Department, Faculty of Science, Al-Azhar University (Girls), Cairo, Egypt. Mohamed.taher0940@gmail.com.
المصدر: Scientific reports [Sci Rep] 2024 Jun 08; Vol. 14 (1), pp. 13201. Date of Electronic Publication: 2024 Jun 08.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
أسماء مطبوعة: Original Publication: London : Nature Publishing Group, copyright 2011-
مواضيع طبية MeSH: Antineoplastic Agents*/pharmacology , Antineoplastic Agents*/chemical synthesis , Antineoplastic Agents*/chemistry , Surface-Active Agents*/chemistry , Surface-Active Agents*/chemical synthesis , Surface-Active Agents*/pharmacology , Anti-Infective Agents*/pharmacology , Anti-Infective Agents*/chemistry , Anti-Infective Agents*/chemical synthesis, Humans ; Structure-Activity Relationship ; Microbial Sensitivity Tests ; Esters/chemistry ; Esters/pharmacology ; Esters/chemical synthesis ; Cell Line, Tumor ; Amino Acids/chemistry
مستخلص: Sugar esters display surface-active properties, wetting, emulsifying, and other physicochemical phenomena following their amphipathic nature and recognize distinct biological activity. The development of nutritional pharmaceuticals and other applications remains of great interest. Herein, three novel homologous series of several N-mono-fatty acyl amino acid glucosyl esters were synthesized, and their physicochemical properties and biological activities were evaluated. The design and preparation of these esters were chemically performed via the reaction of glucose with different fatty acyl amino acids as renewable starting materials, with the suggestion that they would acquire functional characteristics superior and competitive to certain conventional surfactants. The synthesized products are characterized using FTIR, 1 H-NMR, and 13 C-NMR spectroscopy. Further, their physicochemical properties, such as HLB, CMC, Γ max , γ CMC , and A min, were determined. Additionally, their antimicrobial and anticancer efficiency were assessed. The results indicate that the esters' molecular structure, including the acyl chain length and the type of amino acid, significantly influences their properties. The measured HLB ranged from 8.84 to 12.27, suggesting their use as oil/water emulsifiers, wetting, and cleansing agents. All esters demonstrate promising surface-active characteristics, with moderate to high foam production with good stability. Notably, compounds 6-O-(N-dodecanoyl, tetradecanoyl cysteine)-glucopyranose (34, 35), respectively and 6-O-(N-12-hydroxy-9-octadecenoyl cysteine)-glucopyranose (38) display superior foamability. Wetting efficiency increased with decreasing the chain length of the acyl group. The storage results reveal that increasing the fatty acyl hydrophobe length enhances the derived emulsion's stability for up to 63 days. Particularly, including cysteine in these glucosyl esters improves wetting, foaming, and emulsifying potentialities. Furthermore, the esters exhibit antibacterial activity against several tested Gram-positive and Gram-negative bacteria and fungi. On the other hand, they show significant antiproliferative effects on some liver tumor cell lines. For instance, compounds 6-O-(N-12-hydroxy-9-octadecenoylglycine)-glucopyranose (28), 6-O-(N-dodecanoyl, hexadecanoyl, 9-octadecenoyl and 12-hydroxy-9-octadecenoylvaline)- glucopyranose (29, 31, 32 and 33), respectively in addition to the dodecanoyl, hexadecanoyl, 9-octadecenoyl and 12-hydroxy-9-octadecenoyl cysteine glucopyranose (34, 36, 37 and 38), respectively significantly inhibit the examined cancer cells.
(© 2024. The Author(s).)
References: Adv Colloid Interface Sci. 2016 Aug;234:3-26. (PMID: 27181392)
J Endocrinol. 2015 Apr;225(1):1-7. (PMID: 25609734)
Jpn J Cancer Res. 1999 Jun;90(6):669-76. (PMID: 10429660)
Cancer Chemother Pharmacol. 2018 Apr;81(4):705-716. (PMID: 29435611)
Carbohydr Res. 2015 Sep 23;414:32-8. (PMID: 26172090)
Crit Rev Food Sci Nutr. 2021;61(19):3297-3317. (PMID: 32746632)
Appl Biochem Biotechnol. 2014 Feb;172(4):2012-21. (PMID: 24318591)
Pharmaceutics. 2020 Jul 21;12(7):. (PMID: 32708243)
Biotechnol Lett. 2012 Sep;34(9):1597-605. (PMID: 22618240)
RSC Adv. 2021 Oct 6;11(52):33004-33016. (PMID: 35493572)
Daru. 2022 Dec;30(2):407-426. (PMID: 36190619)
Clin Biochem. 2015 Nov;48(16-17):1200-8. (PMID: 25920891)
Chem Pharm Bull (Tokyo). 1981 Feb;29(2):505-13. (PMID: 7273249)
Molecules. 2018 May 08;23(5):. (PMID: 29738519)
J Pharm Sci. 2019 Jun;108(6):1923-1933. (PMID: 30684539)
Food Chem. 2013 Jun 1;138(2-3):1884-91. (PMID: 23411321)
Int J Food Microbiol. 2009 Jan 15;128(3):440-5. (PMID: 19012983)
Eur J Pharm Biopharm. 2018 Mar;124:55-62. (PMID: 29258912)
J Ind Microbiol Biotechnol. 2006 May;33(5):338-42. (PMID: 16402249)
Appl Biochem Biotechnol. 2021 Mar;193(3):822-845. (PMID: 33191449)
Prostaglandins Leukot Essent Fatty Acids. 2013 Sep;89(4):203-13. (PMID: 23932824)
Front Chem. 2018 Feb 12;6:24. (PMID: 29487847)
Crit Rev Food Sci Nutr. 2015;55(5):595-610. (PMID: 24915370)
Chem Pharm Bull (Tokyo). 1977 Jul;25(7):1717-24. (PMID: 908095)
Eur J Pharm Biopharm. 2016 Oct;107:88-96. (PMID: 27373754)
Pharmaceutics. 2021 Oct 01;13(10):. (PMID: 34683888)
Biotechnol Bioeng. 2001 Sep 20;74(6):483-91. (PMID: 11494215)
Pharmaceuticals (Basel). 2019 Dec 17;12(4):. (PMID: 31861227)
Int J Pharm. 2003 Jan 30;251(1-2):195-203. (PMID: 12527189)
Carbohydr Res. 2008 Aug 11;343(12):1999-2009. (PMID: 18374317)
Mini Rev Med Chem. 2013 Feb;13(2):201-10. (PMID: 23278117)
Eur J Pharm Biopharm. 2011 Jan;77(1):43-55. (PMID: 21056658)
3 Biotech. 2016 Dec;6(2):184. (PMID: 28330256)
Adv Colloid Interface Sci. 2016 Feb;228:17-39. (PMID: 26792016)
Appl Biochem Biotechnol. 2012 Apr;166(8):1969-82. (PMID: 22434352)
Food Chem. 2017 Jan 1;214:556-563. (PMID: 27507510)
Food Chem. 2018 Nov 15;266:508-513. (PMID: 30381219)
Front Chem. 2019 Sep 23;7:587. (PMID: 31608269)
Bioresour Technol. 2021 Jun;330:124963. (PMID: 33744735)
Biol Pharm Bull. 2017 Mar 1;40(3):284-289. (PMID: 28003606)
J Agric Food Chem. 2018 Apr 18;66(15):3949-3956. (PMID: 29597347)
J Agric Food Chem. 2018 Jul 5;66(26):6832-6839. (PMID: 29883106)
فهرسة مساهمة: Keywords: Antitumor activity; Cysteine; Glucosyl ester; Hydrophile-lipophile balance (HLB); Surface active performance; Surfactant
المشرفين على المادة: 0 (Antineoplastic Agents)
0 (Surface-Active Agents)
0 (Anti-Infective Agents)
0 (Esters)
0 (Amino Acids)
تواريخ الأحداث: Date Created: 20240608 Date Completed: 20240608 Latest Revision: 20240627
رمز التحديث: 20240627
مُعرف محوري في PubMed: PMC11162424
DOI: 10.1038/s41598-024-62905-3
PMID: 38851845
قاعدة البيانات: MEDLINE
الوصف
تدمد:2045-2322
DOI:10.1038/s41598-024-62905-3